Obstructive sleep apnea (OSA) associates with heightened risks across 20+ health domains from cancer incidence to dementia progression, but a comprehensive 2022 umbrella review…
Obstructive sleep apnoea (OSA) research accelerates dramatically in 2025, propelled by bioinformatics unraveling endotypes, comorbidity deep dives, and multidisciplinary clinics achieving superior outcomes, as…
Obstructive sleep apnea syndrome (OSAS) afflicts nearly 1 billion people worldwide as of 2023, with prevalence surging to 22% in men and 17% in…
Obstructive sleep apnea complicates 65% post-coronary revascularization patients versus 38% non-intervened controls, with a 2025 Sleep and Breathing systematic review/meta-analysis of 12 studies (4,346…
Mouth breathing OSA represents a distinct obstructive sleep apnea phenotype that responds poorly to standard treatments. A 2024 Frontiers in Sleep study shows that…
Polycystic ovary syndrome (PCOS) doubles to triples obstructive sleep apnea syndrome (OSAS) risk in women, with a 2025 Frontiers in Endocrinology systematic review/meta-analysis of…
Sleep apnea management falters with 50% PAP dropout rates, but a 2025 Frontiers in Sleep real-world study of 1,287 patients proves patient-centered pathways achieve…
Choosing between CPAP, oral appliances, or sleep positional therapy for obstructive sleep apnea (OSA) confuses many patients, but a 2025 Frontiers in Medicine meta-analysis…
Obstructive sleep apnea (OSA) casts a wide shadow over health, strongly associating with cancers, atrial fibrillation, diabetes, osteoporosis, and more, as evidenced by a…
Most people with obstructive sleep apnea (OSA) quit CPAP within months because they feel lost, uncomfortable, or unsupported. A comprehensive, patient‑centered sleep apnea care…
